Vacirca Jeff L 4

What Happened
Jeff L. Vacirca, a director of Caris Life Sciences (CAI), was issued 2,492 shares on Feb 26, 2026 as an award/compensation. The shares were valued at $20.06 each for a total of $49,990. This was an award (A) — shares issued in lieu of cash retainer fees — not an open‑market purchase or sale.

Key Details

• Transaction date and price: 2026-02-26; 2,492 shares at $20.06 per share; total ~$49,990.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: Shares were issued in lieu of cash compensation for 2025 board retainer fees. The number of shares was calculated using the ten‑trading‑day average daily VWAP through and including Feb 25, 2026 (per footnote F1).
• Filing timeliness: Form 4 filed 2026-02-27 reporting the 2026-02-26 transaction (filed promptly; no late filing flag).

Context
This issuance reflects routine director compensation converted into equity rather than a market signal of buying or selling intent. Awards paid in stock are common for board retainers and do not necessarily indicate the director’s view on the company’s near‑term prospects.